Skip to main content
Premium Trial:

Request an Annual Quote

Olivier Elemento

Olivier Elemento has been named director of the Caryl and Israel Englander Institute for Precision Medicine at Weill Cornell Medicine, succeeding Mark Rubin, the institute's founding director. Elemento was most recently director of the institute's computational biology group. He is also the associate director of the HRH Prince Alwaleed Bin Talal Bin Abdulaziz Alsaud Institute for Computational Biomedicine and co-leader of the Genetics, Epigenetics, and Systems Biology program in the Sandra and Edward Meyer Cancer Center at Weill Cornell Medicine. He holds a bachelor's degree in mechanical engineering from University Paul Sabatier, a master's degree in mechanical engineering from INSA Toulouse, and a doctorate in computational biology from the University of Montpellier/CNRS.

The Scan

Study Links Evolution of Longevity, Social Organization in Mammals

With the help of comparative phylogenetics and transcriptomics, researchers in Nature Communications see ties between lifespan and social organization in mammals.

Tumor Microenvironment Immune Score Provides Immunotherapy Response, Prognostic Insights

Using multiple in situ analyses and RNA sequence data, researchers in eBioMedicine have developed a score associated with immunotherapy response or survival.

CRISPR-Based Method for Finding Cancer-Associated Exosomal MicroRNAs in Blood

A team from China presents in ACS Sensors a liposome-mediated membrane fusion strategy for detecting miRNAs carried in exosomes in the blood with a CRISPR-mediated reporter system.

Drug Response Variants May Be Distinct in Somatic, Germline Samples

Based on variants from across 21 drug response genes, researchers in The Pharmacogenomics Journal suspect that tumor-only DNA sequences may miss drug response clues found in the germline.